We are investigating Senomyx, Inc. (“Senomyx” or the “Company”) (NasdaqGM: SNMX) relating to the sale of the Company to affiliates of Firmenich, Inc. (‘Firmenich”). As a result of the merger, Senomyx shareholders are only anticipated to receive $1.50 per share in cash for each share of Senomyx common stock they own.